Liver cancer research: Iron-dependent cell death could be key to novel combination therapies

byGoethe University Frankfurt am MainThe light microscope image shows the liver of a diseased mouse in which many tumours have formed. The tumours are slightly darker in colour, have a rounded s

Updated on: December 22,2023

Liver cancer research: Iron-dependent cell death could be key to novel combination therapies

byGoethe University Frankfurt am MainThe light microscope image shows the liver of a diseased mouse in which many tumours have formed. The tumours are slightly darker in colour, have a rounded s

Updated on:December 22,2023

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on: December 18,2023

Marker found for condition that causes numerous tumors

by Cathy Frisinger,UT Southwestern Medical CenterCutaneous neurofibromas cover the back of a patient. Credit: UTSWUT Southwestern researchers have made a major advance in uncovering the biology

Updated on:December 18,2023

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on: November 14,2024

Patient-derived Organoids: Revolutionizing Cancer Research and Treatment

Updated on:November 14,2024

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

Updated on: January 26,2024

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

Updated on:January 26,2024

Study reveals how stem cells respond to environmental signals, with implications for IBD and colorectal cancer

byThe Hospital for Sick ChildrenModel for PIEZO mechanosensing of the ISC niche. Credit:Science(2024). DOI: 10.1126/science.adj7615A new study from The Hospital for Sick Children (Si

Updated on: December 10,2024

Study reveals how stem cells respond to environmental signals, with implications for IBD and colorectal cancer

byThe Hospital for Sick ChildrenModel for PIEZO mechanosensing of the ISC niche. Credit:Science(2024). DOI: 10.1126/science.adj7615A new study from The Hospital for Sick Children (Si

Updated on:December 10,2024

Molecular tumor board provides useful assist in cancer precision medicine

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainThe field of precision cancer medicine has become so complex that even experienced oncologists can find it challenging to decipher

Updated on: December 22,2023

Molecular tumor board provides useful assist in cancer precision medicine

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainThe field of precision cancer medicine has become so complex that even experienced oncologists can find it challenging to decipher

Updated on:December 22,2023

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Updated on: December 20,2023

Unique gene signature could help predict response to chemotherapy

byThe Francis Crick InstituteIn vitro anticancer drug screen. a Volcano plots showing differences in IC50 values between RAS high and low CCLE cell lines. Drugs with enriched target annotations

Updated on:December 20,2023

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024

New study reveals how epithelial cells in the body naturally eliminate 'precancerous' ones

by Waseda UniversityWaseda University researchers identify the underlying mechanism behind the extrusion of precancerous cells by epithelial cells, a mechanism that prevents the formation of canc

Updated on: May 07,2024

New study reveals how epithelial cells in the body naturally eliminate 'precancerous' ones

by Waseda UniversityWaseda University researchers identify the underlying mechanism behind the extrusion of precancerous cells by epithelial cells, a mechanism that prevents the formation of canc

Updated on:May 07,2024

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first

Updated on: August 03,2024

Scientists develop first bone marrow model that supports human stem cells

byUniversity of GlasgowSchematic of the bone marrow (BM) niche microenvironment. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-50054-0Scientists have created the first

Updated on:August 03,2024

A promising treatment for ovarian cancer

by Erin Matthews,Canadian Light SourceOvary. Credit: Public DomainOver 20,000 women across the U.S. and Canada are diagnosed with ovarian cancer annually. The symptoms of this disease are often

Updated on: March 12,2024

A promising treatment for ovarian cancer

by Erin Matthews,Canadian Light SourceOvary. Credit: Public DomainOver 20,000 women across the U.S. and Canada are diagnosed with ovarian cancer annually. The symptoms of this disease are often

Updated on:March 12,2024

Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

by International Society for Stem Cell ResearchSPEDOX-6 causes less damage to heart cells than dox. Left: stem cell derived heart cells treated with dox. Right: stem cell derived heart cells treated w

Updated on: January 04,2024

Using SPEDOX-6 to provide targeted cancer treatment and protect heart cells

by International Society for Stem Cell ResearchSPEDOX-6 causes less damage to heart cells than dox. Left: stem cell derived heart cells treated with dox. Right: stem cell derived heart cells treated w

Updated on:January 04,2024